Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager
- Name
- Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager
- Accession Number
- DBCAT005658
- Description
Not Available
- Drugs
Drug Drug Description Tebentafusp A bispecific gp100 peptide-HLA-directed CD3 T cell engager used to treat unresectable or metastatic uveal melanoma. - Drugs & Drug Targets
Drug Target Type Tebentafusp Melanocyte protein PMEL target